Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag).

about

Recent advances in the application of hydrophilic interaction chromatography for the analysis of biological matrices.Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.

P2860

Q38632209-F53773F1-C747-4A29-B73A-4FD8D1799446 Q38859853-02ECC084-1604-4084-B3A4-C5F7105AB312

P2860

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag).

Item

http://www.wikidata.org/entity/Q43132071

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Bioequivalence of Sandoz methy ...... ith Concerta® (Janssen-Cilag).

@en

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta®

@nl

type

Item

label

Bioequivalence of Sandoz methy ...... ith Concerta® (Janssen-Cilag).

@en

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta®

@nl

prefLabel

Bioequivalence of Sandoz methy ...... ith Concerta® (Janssen-Cilag).

@en

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta®

@nl

P1476

Bioequivalence of Sandoz methy ...... ith Concerta® (Janssen-Cilag).

@en

P2093

Elisabeth Schapperer

http://www.w3.org/2001/XMLSchema#string

François Viel

http://www.w3.org/2001/XMLSchema#string

Heike Daumann

http://www.w3.org/2001/XMLSchema#string

Stéphane Lamouche

http://www.w3.org/2001/XMLSchema#string

Ursula Thyroff-Friesinger

http://www.w3.org/2001/XMLSchema#string

Werner Weitschies

http://www.w3.org/2001/XMLSchema#string

P2860

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects

Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations.

Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate

Treating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.

Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.

Sample size determination for bioequivalence assessment using a multiplicative model.

P304

e00072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRP2.72

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270455873

http://www.w3.org/2001/XMLSchema#string

P698

25692005

http://www.w3.org/2001/XMLSchema#string

P932

4317218

http://www.w3.org/2001/XMLSchema#string

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag).

about

P2860

P2860

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932